Please use this identifier to cite or link to this item: https://doi.org/10.1136/bmjopen-2020-044661
Title: Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
Authors: Han, Shuting
Zhuang, Qingyuan 
Chiang, Jianbang 
Tan, Sze Huey 
Chua, Gail Wan Ying 
Xie, Conghua
Chua, Melvin LK 
Soon, Yu Yang 
Yang, Valerie Shiwen 
Keywords: Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
covid-19
oncology
epidemiology
CLINICAL CHARACTERISTICS
MORTALITY
MULTICENTER
SARS-COV-2
PNEUMONIA
SEVERITY
FEATURES
DISEASE
CHINA
Issue Date: 1-Feb-2022
Publisher: BMJ PUBLISHING GROUP
Citation: Han, Shuting, Zhuang, Qingyuan, Chiang, Jianbang, Tan, Sze Huey, Chua, Gail Wan Ying, Xie, Conghua, Chua, Melvin LK, Soon, Yu Yang, Yang, Valerie Shiwen (2022-02-01). Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ OPEN 12 (2). ScholarBank@NUS Repository. https://doi.org/10.1136/bmjopen-2020-044661
Abstract: Background The COVID-19 has caused significant mortality and morbidity across the globe. Patients with cancer are especially vulnerable given their immunocompromised state. We aimed to determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA). Methods Systematic review was performed through online databases, PubMed, Medline and Google Scholar, with keywords listed in the Methods section (1 November 2019-31 December 2020). Studies with clinical outcomes of at least 10 COVID-19 patients and at least one with a diagnosis of cancer were included. The studies for MA were assessed with PRISMA guidelines and appraised with Newcastle-Ottawa Scale. The data were pooled using a random-effects model using STATA software. The main outcomes were planned before data collection, including proportion of patients with cancer among COVID-19 populations, relative risk (RR) of severe outcomes and death of patients with cancer compared with general COVID-19 patients. Results We identified 57 case series (63 413 patients), with 230 patients with cancer with individual patient data (IPD). We found that the pooled proportion of cancer among COVID-19 patients was 0.04 (95% CI 0.03 to 0.05, I 2 =97.69%, p<0.001). The pooled RR of death was 1.44 (95% CI 1.19 to 1.76) between patients with cancer and the general population with COVID-19 infection. The pooled RR of severe outcome was 1.49 (95% CI 1.18 to 1.87) between cancer and general COVID-19 patients. The presence of lung cancer and stage IV cancer did not result in significantly increased RR of severe outcome. Among the available IPD, only age and gender were associated with severe outcomes. Conclusion Patients with cancer were at a higher risk of severe and death outcomes from COVID-19 infection as compared with general COVID-19 populations. Limitations of this study include publication bias. A collaborative effort is required for a more complete database.
Source Title: BMJ OPEN
URI: https://scholarbank.nus.edu.sg/handle/10635/229737
ISSN: 20446055
DOI: 10.1136/bmjopen-2020-044661
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Impact of cancer diagnoses on the outcomes of patients with COVID-19 a systematic review and meta-analysis.pdf1.91 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.